. The protective effect was also undergone for histological studies.
I. Introduction
Plants have always been a common source of med icament either in the form of t raditional preparat ion or pure active principles. Synthetic products of the modern civilizat ion have overshadowed the usage of herbal med icines. But once having realized their serious side effects people are going back to nature with hopes of safety and security. Medicinal herb is a considered to be a chemical factory as it conta ins multitude of chemical compounds like alkaloids, glycosides, saponins, resins, oleoresins, sesquiterpenes lactones, and essential and fixed oils. World Health Organization has estimated that 80% of the people in the world rely on traditional med icine for primary healthcare needs? And of the 119 plants based drugs used today by modern medicine about 74% are fro m plants traditionally used as herbal cures [1] . It is estimated that the market potential for herbal drugs in the western world alone could range fro m US $ 4.9 b illion to 47 b illion by the year 2000. It is been estimated that higher plants produce more than 100,000 secondary metabolites of which only 15-20% have been chemically characterized [2] . Eclipta prostrata. L. belongs to the family Asteraceae are the most commonly used hepatoprotective herb in the Indian systems of Medicine. The general plant description of E. Prostrata and its medicinal properties was reported by [3] ; [4] ; [5] ; [6] . Root of E. prostrata yielded hientricontanol, hepatocosanol-14 and stigmasterol [7] . The effect of E. prostrata in hepatic injury was studied by [8] , and reported that the alcoholic extract of E.prostrata when administered orally in male rats of Hoffkine strain in a dose of 20 mg/ kg body weight once a day for seven days, paracetamol, and afflato xin induced liver damages. A definite immune inactive property of E. prostrata against, the surface antigen of hepatitis B virus has been reported by [9] . Indigenous drugs containing E. prostrata as one of the constituents also showed positive result as antiviral hepatitis in clinical research [10 ] ; [11 ] . Beneficial effect of aerial parts of E. prostrata on inflammation and liver injury on rats has been reported by [12 ] . The main anti-hepatotoxic princip le Wedelolactone was extracted fro m the leaves of E. prostrata by [13] , [14 ] . [15] Bhargava et al isolated the desmethyl wedelolactone and its glucoside fro m the leaves of E. prostrata.
II.
Materials And Methods
Collection, Phytochemical screening, and Processing of Pl ant material
The fresh plant parts of Eclipta prostrata. L. was collected fro m Periyar Maniammai College of Technology for Women, Vallam, Thanjavur. The habitat, plant species, and the plant parts of E. prostrata were identified, compare, and confirmed with the species preserved in the herbariu m of Tamil Un iversity, Thanjavur. The leaves were allowed to shade dried for three days, pulverized, and used for photochemical analysis and extraction of the active constituent.
1.2
Chromatographic and histological studies of hepatoprotecti ve drug Wedelolactone Wedelolactone was detected by the procedure laid down by Das et al (16) . Ethanolic extract of the plant material was prepared, filtered, and concentrated to 1 ml. 20 micro l o f the extract was spotted on TLC plates. The samples were spotted on activated plates and RF values were calculated. HPLC analysis was performed with a Waters Associates instrument using reverse phase C-18 colu mns of 14x0.8cm and water-methanol (90:10v/v) as developing solvent, and absorbance was detected using UV absorption at 254 n m. 4-6 weeks male Wister albino rats 4-6 weeks, 180-230g were div ided into five groups with six animals each. Group 1-Rats were g iven normal saline = 10ml/Kg/day Group 2 -Rats were given saline (Control) Group 3 -Rats were given standard Group 4 and 5 was administered with 100 mg/Kg and 200mg/Kg E. prostrata extracts in PEG. After 24 hours the rats were sacrificed and blood was collected in a non heparinisede tube. Seru m was separated by centrifugation at 2500 rp m for 10 min ad used for the determination of SGOPT, SGOT, A LT, CP, and bilirubin levels. Invitro determination of SGOT was done by the method of Ladue et al (1954) . For histological evaluation, hepatative tissues sections were cut and stained with haemto xy lin-eosin for histological examination.
III. Results And Discussion
The ethanol soluble plant constituents are extracted and concentrated by distillat ion process and subjected for further phytochemical analysis. Qualitative phytochemical analysis reveals the presence of carbohydrates, alkalo ids, phytosterols, saponins, tannins and phenolic co mpounds, flavanoids, and lignin in the leaf extract of E. prostrata. The presences of the phytochemical constituents are indicated in Table 1 . Tannins and P henolic compounds + 7.
P rotein and aminoacids + 8.
Fixed oils and fats -9.
Flavanoid + 10.
Lignin + Thin layer chro matographic plates spotted with ethanolic extract of leaves of E.prostrata. The band at Rf value 0.58 was identified as Wedelolactone. The identification of wedelolactone was done by the HPLC analysis Graph 1. The component separated out at a rentention time of 6.48 was identified as wedelolactone. The serum collected were subjected for different analysis and the results of SGOT, SGPT, ALP, b ilirubin, , glutathione peroxidase, catalase, creatin ine, and glucose level in the serum. The results are provided in Table 2 . 
Efficacy Studies of Hepatoprotective Drug Isolated from Eclipta prostrata. L.
Histopathological results: An accurate estimator of the amount of liver cell inflammat ion or death can only be made by liver biopsy (Figure 2 ). The liver tissues are excised fro m normal, standard and E.prostrata treated male Wistar rates. The severity of liver disease due to CCl4 induction was compared with the normal tissue of liver. The tissue from the animals treated with 200 mg/KG of the ethanolic extract of E. prostrate was found to be similar to that of animals treated with Silimarin. In the same mann er, 100mg/ Kg of ethanolic ext ract of E. prostrate showed a positive protective effect, but lesser than that of Silimarin.
Graph 1: Identification of Wedelolactone by the HPLC analysis
The presence of Wedelolactone is identified by thin layer chromatographyic method and RF value is found to be 5.6 instead of 5.8 observed by Das et a l (1990). About HPLC, the retention time of Wedelactone of our present study is 6.48 minutes, instead of 7 minutes reported in earlier studies. Primary liver d iseas es (necrosis, obstructive jaundice, and carcino ma, viral or to xic hepatitis) as well as liver damage to the other causes result in elevated SGOT levels. The normal, standard values of liver function test of SGOT id 5-40 IU/ L. As the SGOT levels of our pres ent study is within the range. It denotes that E. prostrata is found to be effective in controlling the necrosis caused due to the CCL4 induced liver damages. Elevated level of SGPT is associated with liver disease or damage, myocardial infarct ion, muscular\ dystrophy and cholecystitis. The normal value of liver function test of SGPT is 5-35 IU/L. The result of our present study is found to be within the range of the normal standard values, that indicates the efficacy of the drug against liver damages. Increase in the serum alkaline phosphatase level can lead to the elevated bile duct obstruction. It also causes the bone disorders in the elevated level. The normal value of alkaline phosphatase is 30-85 IU/ L. In our study, the range falls with in the normal values. Hence the efficacy against E. prostrata is proved. Large amount of acid phosphatase is present in adult prostrate tissues in prostatic secretion. The normal value of ACP is 5-27 U/ L. As the result of our present study is within the standard range infers the positive efficacy against prostratic secretion. Increased levels of bilirubin are associated with biliary obstruction and hepatocellular diseases as well as hemo lytic disorders in adults and newborns. The normal value of direct bilirubin is 0.0-0.4 mg/dL. As the result obtained in our study is within the range, it denotes that E. prostrate controls the biliary obstruction. The glutothine peroxidase, SOD, catalase, creatinine and glucose is found to be more or less similar to the normal values. Dosage levels of E.prostrata administered to the rats, both found to contain the hepatoprotective action against CCL4 induction. It was found that the dose of 100 mg/Kg of body weight. Hence the present study of E. prostrata, experimentally p roved that it is found to be effective drug in the treatment of hepatic damages. Histopathological studies demonstrated the carbon tetrachloride causes fecal necrosis, portal infiltration, fatty change, kupffer cell hyperplasia and hydropic change. In the treated groups, necrosis, which is more severe form of inju ry, is markedly prevented; milder form o f injury li ke fatty change and reduced necrosis persisted in extracts. CCL4 is metabolized by the mixed function of oxidase system in the endoplasmic reticu lu m of the liver. Cleavage of the carbon -chloride bond results in the formation of free trichloro methyl radicals (CCL3) which are h ighly unstable and immediately react with memb rane components.
They form covalent bonds woth unsaturated fatty acids or abstract a hydrogen atom fro m the unsaturated fatty acids of membrane lipids, resulting in the production of chloro form and lipid radicals which react with molecular o xygen, this initiates peroxidative decomposition of phospholipids in the endoplasmic reticulu m. The pero xidation process results in the release of soluble products that affect other membranes, such as cell membranes. It has been found that microsomal o xidation of chloroform results in the format ion of phosgene. It is thought that a secondary metabolite causes cell death. Thus protective agents, Wedelolactone and demethyl wedelo lactone of leaves of E. prostrata against CCL4 mediated lip id peroxidation by inhibiting the generation of free radical derivatives or as a result of the antioxidant activity of the protective agent itself.
IV. Conclusion
Standardization of E. prostata L. was done by various physiochemical analyses and is also comparative to the stantdards as stated in the Indian Pharmacopoeia. Screening of ethanolic extacts of E. prostata revealed the presence of various phytochemicals. Identification of the active princip le, Wedelolactone was done by various chromatographic methods such as HPLC and TLC. Therapeutic efficacy of E. p rostrate was evaluated using male Wistar rats and it was found that the curative effect of E. prostata was comparable to that of that standard drug Silimarin. The optimu m effect ive dosage was found to be 200mg of ethanolic ext ract per body weight of the experimental animals used. The plant E. prostata. L. under the present study is found to be more significant in clin ical use ad depicted in the pharmacological studies. The d rug was standardized pharmacognostically and the optimu m dosage was found to be 200 mg/kg body weight of the animal. Technically and economically feasible protocol was developed for optimization of the secondary metabolite of E. p rostrate. The plant E. prostata. L. under the present study is found to be more significant in clinical use ad depicted in the pharmacological studies. The drug was standardized pharmacognostically and the optimu m dosage was found to be 200 mg/kg body weight of the animal. Technically and economically feasib le protocol was developed for optimization of the secondary metabolite of E. prostrat a.
